Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
150 participants
OBSERVATIONAL
2012-01-02
2018-02-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endolaparoscopic Versus Immediate Surgery for Obstructing Colorectal Cancers
NCT00164879
Defunctioning Cannula Ileostomy After Lower Anterior Resection of Rectal Cancer
NCT01980238
Use of One Kind of Controllable Tube Ileostomy in the Low Rectal Cancer
NCT02012023
Transanal Versus Laparoscopic Total Mesorectal Excision for Rectal Cancer.
NCT03413904
Early Closure of Protective Ileostomy in Rectal Cancer Patients
NCT02997267
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
patients who underwent to laparoscopic TME, with elective diverting ileostomy for rectal cancer
elective diverting ileostomy
Group 2
patients who underwent to laparoscopic TME, without elective diverting ileostomy for rectal cancer
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
elective diverting ileostomy
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients submitted to elective Anterior Rectal Resection
Exclusion Criteria
* urgent surgery
67 Years
86 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Campus Bio-Medico University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vincenzo La Vaccara
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11.17 OSS Comet CBM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.